BioCentury | Sep 10, 2015
Tools & Techniques
Undiscovered country
...method is inefficient and costly because the transcripts from the abnormal genes are often rare. NuGen Technologies Inc....
...cancer that might be missed with total RNA sequencing. Douglas Amorese, VP of R&D at NuGen...
...resulting fused genes can be transcribed, spliced into productive mRNAs and translated into abnormal proteins. NuGen's...
...cancer that might be missed with total RNA sequencing. Douglas Amorese, VP of R&D at NuGen...
...resulting fused genes can be transcribed, spliced into productive mRNAs and translated into abnormal proteins. NuGen's...